Literature DB >> 21116253

Insulin regulation of monoamine signaling: pathway to obesity.

Kevin D Niswender1, Lynette C Daws, Malcolm J Avison, Aurelio Galli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21116253      PMCID: PMC3055525          DOI: 10.1038/npp.2010.167

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

1.  Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis.

Authors:  Sabrina D Robertson; Heinrich J G Matthies; W Anthony Owens; Vidiya Sathananthan; Nicole S Bibus Christianson; J Phillip Kennedy; Craig W Lindsley; Lynette C Daws; Aurelio Galli
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 2.  Is dopamine a physiologically relevant mediator of feeding behavior?

Authors:  Richard D Palmiter
Journal:  Trends Neurosci       Date:  2007-06-29       Impact factor: 13.837

3.  Brain dopamine and obesity.

Authors:  G J Wang; N D Volkow; J Logan; N R Pappas; C T Wong; W Zhu; N Netusil; J S Fowler
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

Review 4.  Insulin, leptin, and food reward: update 2008.

Authors:  Dianne P Figlewicz; Stephen C Benoit
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-22       Impact factor: 3.619

5.  Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet.

Authors:  Kelly A Posey; Deborah J Clegg; Richard L Printz; Jaeman Byun; Gregory J Morton; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Denis G Baskin; Jay W Heinecke; Stephen C Woods; Michael W Schwartz; Kevin D Niswender
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-30       Impact factor: 4.310

6.  Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.

Authors:  Jason M Williams; W Anthony Owens; Gregory H Turner; Christine Saunders; Concetta Dipace; Randy D Blakely; Charles P France; John C Gore; Lynette C Daws; Malcolm J Avison; Aurelio Galli
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

  6 in total
  13 in total

Review 1.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

2.  mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Authors:  Olga I Dadalko; Michael Siuta; Amanda Poe; Kevin Erreger; Heinrich J G Matthies; Kevin Niswender; Aurelio Galli
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

Review 3.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 4.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 5.  You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists.

Authors:  Michelle G Baladi; Lynette C Daws; Charles P France
Journal:  Neuropharmacology       Date:  2012-02-23       Impact factor: 5.250

Review 6.  Oxidative and nitrative stress in neurodegeneration.

Authors:  Catherine A Cobb; Marsha P Cole
Journal:  Neurobiol Dis       Date:  2015-05-27       Impact factor: 5.996

7.  Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism.

Authors:  W Anthony Owens; Jason M Williams; Christine Saunders; Malcolm J Avison; Aurelio Galli; Lynette C Daws
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

8.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

Review 9.  Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward.

Authors:  India A Reddy; Gregg D Stanwood; Aurelio Galli
Journal:  Neurochem Int       Date:  2013-10-16       Impact factor: 3.921

10.  Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding.

Authors:  Nicole Speed; Christine Saunders; Adeola R Davis; W Anthony Owens; Heinrich J G Matthies; Sanaz Saadat; Jack P Kennedy; Roxanne A Vaughan; Rachael L Neve; Craig W Lindsley; Scott J Russo; Lynette C Daws; Kevin D Niswender; Aurelio Galli
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.